KR890005202B1 - Process for preparing 4,4-dimethyl-1-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-2,6-piperidine - Google Patents
Process for preparing 4,4-dimethyl-1-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-2,6-piperidine Download PDFInfo
- Publication number
- KR890005202B1 KR890005202B1 KR1019870004267A KR870004267A KR890005202B1 KR 890005202 B1 KR890005202 B1 KR 890005202B1 KR 1019870004267 A KR1019870004267 A KR 1019870004267A KR 870004267 A KR870004267 A KR 870004267A KR 890005202 B1 KR890005202 B1 KR 890005202B1
- Authority
- KR
- South Korea
- Prior art keywords
- dimethyl
- butyl
- formula
- pyrimidinyl
- piperazinyl
- Prior art date
Links
- BCLSJHWBDUYDTR-UHFFFAOYSA-N CCCNCCO Chemical compound CCCNCCO BCLSJHWBDUYDTR-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
내용 없음.No content.
Description
본 발명은 구조식(Ⅰ)로 표시된는 4,4-디메틸-1-[4-[4-(2-피리미디닐)-1-피페라지닐]부틸]-2,6-피페리딘 디온의 제조방법에 관한 것이다.The present invention provides the preparation of 4,4-dimethyl-1- [4- [4- (2-pyrimidinyl) -1-piperazinyl] butyl] -2,6-piperidine dione represented by the structural formula (I). It is about a method.
상기 구조식(Ⅰ)의 화합물은 공지의 화합물로서 Journal of Medicinal Chemistry, 26(2), 194(1983), 미국특허 제1,423,049호에 그 제조방법이 기재되어 있다.Compounds of the above formula (I) are known compounds and are described in the Journal of Medicinal Chemistry, 26 (2), 194 (1983), US Pat. No. 1,423,049.
미국특허 제4,423,049호에는 이 구조식(Ⅰ)의 디메틸-1-[4-[4-(2-피리미디닐)-1-피페라지닐]부틸]-2,6-피페리딘 디온을 다음과 같은 방법 A, B, C, D의 4가지 방법으로 제조하고 있다.U.S. Patent 4,423,049 discloses dimethyl-1- [4- [4- (2-pyrimidinyl) -1-piperazinyl] butyl] -2,6-piperidine dione of formula (I) as follows. It is manufactured by four methods, the same method A, B, C, D.
[방법 A][Method A]
[방법 B][Method B]
[방법 C][Method C]
[방법 D][Method D]
이들 공지의 제조방법들은 모두 기본출발물질로 사용되고 있는 구조식(Ⅲ), (Ⅴ), (Ⅶ), (Ⅷ)을 제조하기 위해 고가으 2-할로피리미딘을 사용하거나 다음과 같은 여러공정을 거쳐서 구조식(Ⅴ)의 물질을 제조해야 하는 불편이 있다.All of these known manufacturing methods use expensive 2-halopyrimidines to prepare structural formulas (III), (V), (iii) and (iii), which are used as basic starting materials, or through various processes as follows. It is inconvenient to manufacture the material of formula (V).
특히, 구조식(Ⅲ)의 1-(4-아미노부틸)-4-(2-피리미디닐)피페라진의 제조는 1-(3-시아노프로필)-4-(2-피리미디닐)피페라진을 라니닉켈을 촉매로 하여야 하는 까다로운 반응이다.In particular, the preparation of 1- (4-aminobutyl) -4- (2-pyrimidinyl) piperazine of formula III is 1- (3-cyanopropyl) -4- (2-pyrimidinyl) pipe Razine is a tricky reaction that requires catalyzing raninickel.
방법 A는 구조식(Ⅱ)의 3,3-디메틸글루타릭안하이드라이드와 구조식(Ⅲ)의 1-(4-아미노부틸)-4-(2-피리미디닐)피레라진으로부터 구조식(Ⅰ)을 제조하는 방법인데 20시간 가열환류하면서 H2O를 계속 제거해야하는 불편함이 있다.Method A was prepared from 3,3-dimethylglutaric anhydride of formula (II) and 1- (4-aminobutyl) -4- (2-pyrimidinyl) pyrazine of formula (III). It is a method of manufacturing, there is an inconvenience to continue to remove H 2 O while refluxing for 20 hours.
또한, 방법 D도 구조식(Ⅹ)의 4,4-디메틸-1-[4-(피페라지닐)]부틸-2,6-피페리딘 디온과 2-클로로피리미딘을 반응 시켜 구조식(Ⅰ)의 화합물을 제조하는 것으로 이 방법 역시 고가의 2-클로로피리미딘을 사용하며, 80℃ 내지 170℃의 고온에서 장시간 반응시켜야 하는 결점이 있다.In addition, Method D also reacts 4,4-dimethyl-1- [4- (piperazinyl)] butyl-2,6-piperidine dione with 2-chloropyrimidine of Structural Formula (I) to Structural Formula (I) This method also uses expensive 2-chloropyrimidine to prepare a compound of, there is a drawback to react for a long time at a high temperature of 80 ℃ to 170 ℃.
본 발명은 이러한 결점을 개선한 방법으로 구조식(ⅩⅡ)의 4,4-디메틸-1-[4-[디(2-할로에틸)아미노]부틸]-2,6-피페리딘 디온과 구조식 (ⅩⅢ)의 2-아미노피리미딘을 출발물질로 사용하여 목적물인 구조식(Ⅰ)의 화합물을 비교적 간단한 반응조작을 통하여 높은 수율로 제조할 수 있는 특징을 갖고 있는 경제적인 방법이다. 또한 종전의 방법과 같이 구조식(Ⅲ), (Ⅴ), (Ⅶ), (Ⅷ)과 같은 중간체를 거치지 않으므로 고가의 2-할로피리미딘을 사용하거나 다단계의 공정을 거쳐서 제조할 필료가 없는 매우 경제적이고 편리한 방법이다.The present invention provides a method of improving the above-mentioned shortcomings by using 4,4-dimethyl-1- [4- [di (2-haloethyl) amino] butyl] -2,6-piperidine dione of structural formula (XII). Using 2-aminopyrimidine of XIII) as a starting material, it is an economical method that can produce the compound of formula (I), which is the target compound, in a high yield through a relatively simple reaction operation. In addition, since it does not go through intermediates like Structural Formulas (III), (V), (iii), and (iii) as in the previous method, it is very economical that there is no necessity to use expensive 2-halopyrimidine or to prepare it through a multi-step process. And convenient way.
본 발명의 방법을 좀 더 상세히 설명하면, 출발물질로 사용되는 구조식(ⅩⅡ)의 화합물을 구조식(Ⅱ)의 3,3-디메틸글루타릭안하이드라이드와 구조식(ⅩⅣ)의 1,4-디ㅁ아미노부탄을 빙초산 용매를 사용하여 환류하에 2내지 10시간동안 반응 시켜서 쉽게 얻을 수 있는 구조식(ⅩⅤ)의 4,4-디메틸-1-(4-아미노부틸)-2,6-피리딘 디올을In more detail, the method of the present invention, the compound of formula (XII) to be used as a starting material is 3,3-dimethyl glutaric hydride of the formula (II) and 1,4-dich of the formula (XIV) 4,4-dimethyl-1- (4-aminobutyl) -2,6-pyridine diol of Structural Formula (XV) which can be easily obtained by reacting aminobutane for 2 to 10 hours under reflux using a glacial acetic acid solvent.
염기성 축합체의 존재 또는 부재하에 적당한 유기용매 중에서 1,2-디할로에탄과 반응시켜 제조하거나 혹은 2-할로에탄올과 반응시킨 다음 할로겐화하여 얻는다.Prepared by reaction with 1,2-dihaloethane in a suitable organic solvent in the presence or absence of basic condensates or by reaction with 2-haloethanol and then halogenated.
또는or
본 발명의 특징인 구조식(ⅩⅡ)화합물과 2-아미노피리미딘을 반응시켜서 구조식(Ⅰ)을 목적물을 얻는 반응은 염기성 축합체의 존재 또는 부재하에 적당한 유기용매 중에 진행된다.The reaction for obtaining the target compound of formula (I) by reacting the compound of formula (XII) and 2-aminopyrimidine, which is a feature of the present invention, is carried out in a suitable organic solvent in the presence or absence of a basic condensate.
유기용매의 예로는 벤젠, 톨루엔 등의 방향족 탄산수소류, 메탄올, 부탄올, 아밀알콜 등의 알콜류, 디메틸포름아마이드, 아세토니트릴 등을 열거 할 수 있으며, 염기성 축합체의 예로는 탄산나트륨, 탄산칼륨, 탄산수소나트륨, 탄산수소칼륨등의 탄산염, 수산화나트륨, 수산화칼륨 등의 금속수산화물, 타트륨메틸레이트, 나트륨에틸레이트 등의 금속 알콜레이트, 피리딘, 트리에틸아민 등과 같은 제 3급아민을 열거할 수 있다. 이 때 구조식(ⅩⅡ)화합물양에 대한 구조식(ⅩⅢ)화합물양의 비율은 동몰이상 사용하며, 본 반응은 40℃ 내지 150℃에서 2 내지 10시간동안 수행한다.Examples of the organic solvent include aromatic hydrogen carbonates such as benzene and toluene, alcohols such as methanol, butanol and amyl alcohol, dimethylformamide and acetonitrile, and examples of the basic condensate include sodium carbonate, potassium carbonate and hydrogen carbonate. Carbonates such as sodium and potassium hydrogen carbonate, metal hydroxides such as sodium hydroxide and potassium hydroxide, metal alcoholates such as tartrium methylate and sodium ethylate, and tertiary amines such as pyridine and triethylamine. At this time, the ratio of the amount of the compound of the formula (XIII) to the amount of the compound of the formula (XII) is used in an equimolar amount or more, and the reaction is carried out at 40 ° C. to 150 ° C. for 2 to 10 hours.
또한, 구족식(ⅩⅡ)의 화합물은 공지의 구조식(Ⅳ)화합물과 디에탄올아민을 반응시켜 4,4-디메틸[4-[디(2-하드록시)-아미노]부틸]-2,6-피페리딘 디온을 얻은 다음 할로겐화제와 반응시키거나 또는 구조식(Ⅳ)화합물과 디(2-할로에틸)아민을 반응시켜 제조할 수도 있다.In addition, the compound of the group (XII) is reacted with a known structural formula (IV) compound and diethanolamine to give 4,4-dimethyl [4- [di (2-hydroxy) -amino] butyl] -2,6- It may be prepared by obtaining piperidine dione and then reacting with a halogenating agent or by reacting a compound of formula (IV) with di (2-haloethyl) amine.
또는or
본 발명의 제조방법을 실시예에 따라서 자세히 설명하면 다음과 같다.Hereinafter, the manufacturing method of the present invention will be described in detail with reference to Examples.
[실시예 1]Example 1
4,4-디메틸-1-(4-아미노부틸)-2,6-피페리딘 디온(ⅩⅤ)의 제조.Preparation of 4,4-dimethyl-1- (4-aminobutyl) -2,6-piperidine dione (XV).
26.4g(0.3몰)의 1,4-디아미노부탄을 200ml의 빙초산에 용해시키고 14.2g(0.1몰)의 3,3-디메틸글루타릭안하이드라이드를 30분에 걸쳐 서서히 가한후 환류하에서 8시간 동안 반응시킨다. 반응이 끝나면 용매를 감압 농축하여 제거하고 잔류물을 클로로포름으로 추출한 후 물로 세척한다. 무수황산 마그네슘으로 탈수, 여과한 후 감압농축하여 표제의 화합물 15.5g(수율73%)을 얻는다.26.4 g (0.3 mole) of 1,4-diaminobutane was dissolved in 200 ml of glacial acetic acid and 14.2 g (0.1 mole) of 3,3-dimethylglutaric anhydride was slowly added over 30 minutes, followed by 8 hours at reflux. To react. After the reaction is completed, the solvent is removed by concentration under reduced pressure, and the residue is extracted with chloroform and washed with water. Dehydrated with anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to give 15.5 g (73% yield) of the title compound.
원소분석 : C11H20N2O2 Elemental Analysis: C 11 H 20 N 2 O 2
이론치(%) : C ; 62.24, H ; 9.50, N ; 13.20Theoretical value (%): C; 62.24, H; 9.50, N; 13.20
실측치(%) : C ; 62.38, H ; 9.36, N ; 13.07Found (%): C; 62.38, H; 9.36, N; 13.07
[실시예 2]Example 2
4,4-디메틸-1-[4-[디(2-클로로에틸)아미노]부틸]-2,6-피페리딘 디온(ⅩⅡ)의 제조Preparation of 4,4-dimethyl-1- [4- [di (2-chloroethyl) amino] butyl] -2,6-piperidine dione (XII)
4.3g(0.02몰)의 4,4-디메틸-1-(4-아미노부틸)-2,6피페리딘 디온 14.3g(0.1몰)의 1-브로모-2-클로로에탄올 30ml의 아세토니트릴에 현탁시키고 5.5g(0.04몰)의 탄산칼륨을 가하여 환류하에 10시간동안 반응시킨다. 반응 혼합물을 여과하고, 감압하에 용매를 농축한 후 클로로포름으로 추출하여 물로 세척한다. 무수황산마그네슘으로 탈수 여과 후 감압농축하여 표제의 화합물4.4g(수율64%)을 얻는다.To 4.3 g (0.02 mole) of 4,4-dimethyl-1- (4-aminobutyl) -2,6 piperidine dione 14.3 g (0.1 mole) of 1-bromo-2-chloroethanol 30 ml acetonitrile Suspension was added and 5.5 g (0.04 mol) of potassium carbonate was added and reacted under reflux for 10 hours. The reaction mixture is filtered, the solvent is concentrated under reduced pressure, extracted with chloroform and washed with water. Dehydration filtration with anhydrous magnesium sulfate and concentration under reduced pressure gave 4.4 g (64% yield) of the title compound.
원소분소 : C15H26C2N2O2 Elemental division: C 15 H 26 C 2 N 2 O 2
이론치(%) : C ; 53.42, H ; 7.77, N ; 8.31Theoretical value (%): C; 53.42, H; 7.77, N; 8.31
실측치(%) : C ; 53.21, H ; 7.80, N; 8.21Found (%): C; 53.21, H; 7.80, N; 8.21
[실시예 3]Example 3
4,4-디메틸-1-[4-[디(2-클로로에틸)아미노]부틸]-2,6-피페리딘 디온(ⅩⅡ)의 제조Preparation of 4,4-dimethyl-1- [4- [di (2-chloroethyl) amino] butyl] -2,6-piperidine dione (XII)
4.3g(0.02몰)의 4,4-디메틸-1-(4-아미노부틸)-2,6-피페리딘 디온과 12.5g(0.01몰)의 2-브로모에탄올을 30ml의 아세토니트릴에 현탁시키고 5.5g(0.04몰)의 탄산칼륨을 가하여 환류하에 15시산동안 반응시킨다.4.3 g (0.02 mole) of 4,4-dimethyl-1- (4-aminobutyl) -2,6-piperidine dione and 12.5 g (0.01 mole) of 2-bromoethanol are suspended in 30 ml of acetonitrile. 5.5 g (0.04 mole) of potassium carbonate was added thereto and reacted for 15 hours under reflux.
반응혼합물을 여과하고 감압하에 용매를 제거하여 얻어진 잔류물에 20ml의 벤젠을 가한후 피리딘19ml를 첨가하고 3ml의 염화치오닐을 서서히 가한다음 실온에서 5시간동안 반응시킨다. 반응이 끝나면 물로 1회 세척하고 무수황산마그네슘으로 탈수, 여과 후 농축하여 표제의 화합물 4.9g(수율72%)을 얻는다.After the reaction mixture was filtered and the solvent was removed under reduced pressure, 20 ml of benzene was added to the residue, 19 ml of pyridine was added, and 3 ml of thionyl chloride was slowly added, followed by reaction at room temperature for 5 hours. After the reaction was washed once with water, dehydrated with anhydrous magnesium sulfate, filtered and concentrated to give 4.9 g (72% yield) of the title compound.
[실시예 4]Example 4
4,4-디메틸-1-[4-[4-(2-피리미디닐)-1-피페라지닐]부틸]-2,6-피페리딘 디온염산염(Ⅰ)제조Preparation of 4,4-dimethyl-1- [4- [4- (2-pyrimidinyl) -1-piperazinyl] butyl] -2,6-piperidine dione hydrochloride (I)
3.4g(0.01몰)의 4,4-디메틸-1-[4-[디-(2-클오오네틸)-아미노]부틸]-2,6-피페리딘 디온과 2.4g(0.03몰)의 2-아미노피리미딘 그리고 2.8g(0.02몰)의 탄산칼륨을 30ml의 아밀알콜에 현탁시키고 환류하에 8시간 동안 반응시켰다. 다음에 50% 탄산칼륨 용액 10ml를 첨가하고 홈합물을 감압 농축하였다.2.4 g (0.03 mole) of 3.4 g (0.01 mole) of 4,4-dimethyl-1- [4- [di- (2-clonethyl) -amino] butyl] -2,6-piperidine dione 2-aminopyrimidine and 2.8 g (0.02 mol) of potassium carbonate were suspended in 30 ml of amyl alcohol and reacted under reflux for 8 hours. Then 10 ml of 50% potassium carbonate solution was added, and the home mixture was concentrated under reduced pressure.
얻어진 잔류물은 벤젠으로 추출하고 물로 세척한 다음 무수황산마그네슘으로 탈수, 여과, 감압농축하여 4.1g의 유상의 물질을 얻었다. 이것을 증류하여 염기, (비점 210-230℃, 0.01mmHg)2.8g을 얻었다.The obtained residue was extracted with benzene, washed with water, dehydrated with anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to obtain 4.1 g of an oily substance. This was distilled off and 2.8g of base and (boiling point 210-230 degreeC, 0.01mmHg) were obtained.
원소분석 : C19H29N5O2·HCIElemental analysis: C 19 H 29 N 5 O 2 · HCI
이론치(%) : C ; 57.64, H ; 7.64, N ; 17.69Theoretical value (%): C; 57.64, H; 7.64, N; 17.69
실측치(%) : C ; 57.61, H ; 7.40, N ; 17.60Found (%): C; 57.61, H; 7.40, N; 17.60
IR(KBr) : 1120, 1360, 1450, 1555, 1587, 1670, 1720, 2450, 2960cm-1 IR (KBr): 1120, 1360, 1450, 1555, 1587, 1670, 1720, 2450, 2960 cm -1
NMR(DMSO-d6) : 1.00(6H, s), 1.60(4H, m), 2.56(4H, m), 3.09(4H, m), 3.55(6H, m), 4.67(2H, bd, 13.3Hz), 6.75(1H, t, 4.6Hz), 8.45(2H, d, 4.6Hz), 11.70(1H, bs)NMR (DMSO-d6): 1.00 (6H, s), 1.60 (4H, m), 2.56 (4H, m), 3.09 (4H, m), 3.55 (6H, m), 4.67 (2H, bd, 13.3Hz ), 6.75 (1H, t, 4.6 Hz), 8.45 (2H, d, 4.6 Hz), 11.70 (1H, bs)
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019870004267A KR890005202B1 (en) | 1987-05-01 | 1987-05-01 | Process for preparing 4,4-dimethyl-1-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-2,6-piperidine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019870004267A KR890005202B1 (en) | 1987-05-01 | 1987-05-01 | Process for preparing 4,4-dimethyl-1-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-2,6-piperidine |
Publications (2)
Publication Number | Publication Date |
---|---|
KR880013921A KR880013921A (en) | 1988-12-22 |
KR890005202B1 true KR890005202B1 (en) | 1989-12-18 |
Family
ID=19261114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019870004267A KR890005202B1 (en) | 1987-05-01 | 1987-05-01 | Process for preparing 4,4-dimethyl-1-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-2,6-piperidine |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR890005202B1 (en) |
-
1987
- 1987-05-01 KR KR1019870004267A patent/KR890005202B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR880013921A (en) | 1988-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR870001045B1 (en) | Process for preparing 2-(4-(4,4-dialkyl-2,6-piperidindion-1-yl)butyl)piperayinyl)pyrimidines | |
CA2686429C (en) | Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile | |
US5225585A (en) | Production of fluoxetine and new intermediates | |
JPS62289544A (en) | Fluorine-containing compound | |
US6140501A (en) | Substituted [2-(1-piperazinyl)ethoxy]methyl compounds | |
US5663340A (en) | N-(2-amino-4,6-dichloropyrimidine-5-yl)formamide, and a process for its preparation | |
PL161374B1 (en) | Method of obtaining 2-(2-(4(/4-chlorophenyl/phenylomethyl)-1-piperazinyl)ethoxy)acetic acid and its dichydrochloride | |
US4824949A (en) | Process for the preparation of pyrimidines | |
EP1087966B1 (en) | Chemical synthesis of morpholine derivatives | |
KR890005202B1 (en) | Process for preparing 4,4-dimethyl-1-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-2,6-piperidine | |
EP0105702B1 (en) | Dioxocyclobutene compounds | |
US4143227A (en) | Process for substituted 5-benzyl-2,4-diamino-pyrimidines | |
KR101139431B1 (en) | New method for producing imatinib base | |
KR890005201B1 (en) | Process for preparing 4,4-dimethyl-1-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-2,6-piperidine | |
US4292431A (en) | Process for the production of hydroxymethylimidazoles | |
US4255574A (en) | Process for preparing 2,4-diamino-pyrimidines | |
PL113012B1 (en) | Method of manufacture of 2/4-substituted piperazinyl-1/-4-aminoquinazolines | |
US5330985A (en) | 2-amino-N-[[4-(aminocarbonyl)pyrimidin-2-yl]amino]-alkyl]pyrimidine-4-carboxamide derivatives, their preparation and pharmaceutical compositions containing them | |
KR890000705B1 (en) | Process for preparing n-(2-pyrimidinyl)piperazinyl buthyl azaspirodecanedion | |
US4620002A (en) | 2-pyrimidyl alkanesulfonates | |
US4729995A (en) | Pyrimidine 2,4-dioxamate compounds and pharmaceutical compositions | |
US4424170A (en) | Halostilbene sulfonates useful as starting materials for making fluorescent whitening agents of the 4,4'-distyrylbiphenyl series | |
WO2000052000A1 (en) | A process for the preparation of 2-{2-[4-(diphenylmethyl)-1-piperazinyl]ethoxy}acetic acid compounds or salts thereof | |
JPH0730037B2 (en) | Pyrimidinylpropionic acid derivative | |
KR900007314B1 (en) | Process for preparing n-(methoxyacetyl)-n-(2,l-dimethyl phenyl)-o-amino-oxazolidine-2-one |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 19930330 Year of fee payment: 12 |
|
LAPS | Lapse due to unpaid annual fee |